Canton Strategic Holdings Inc. (CNTN)
NASDAQ: CNTNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CNTN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $98.78M
- P/E (TTM)
- 20.17
- EPS (TTM)
- $0.06
- Dividend yield
- None
- 52-week range
- 1.19 – 5.83
- Day range
- 1.19 – 1.28
- Volume / Avg
- 876.71K / 763.63K
- Beta
- —
- Shares outstanding
- 81.64M
52-week range
CNTN stock today
On Nov 20, CNTN ended the session at $1.21, shedding $0.02 (1.63%), versus the S&P 500's 3.70% decline. Shares are 79.2% below their 52-week high of $5.83, set on Feb 2, 2026 and 1.7% above the 52-week low of $1.19, near the bottom of the past year's range. CNTN is down 60.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 50.6%.
Canton Strategic trades at 20.2x its trailing twelve-month earnings per share of $0.06.
Summary generated from market data by MetaCap's automated system. Methodology
About Canton Strategic
Company profileCanton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Mark Wendland
- Headquarters
- New York, NY
- Employees
- 12
- IPO year
- 2022
- Website
- cantonstrategic.com
Financial highlights
Full financialsCanton Strategic reported a net loss of $35.9 million, compared with a loss of $12.2 million a year earlier. Diluted earnings per share came in at -$1.12.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-35.92M | $-12.20M | $-9.32M | $-8.47M | $-2.21M |
| EPS (diluted) | $-1.12 | $-9.41 | $-107.02 | $-18.72 | $-0.35 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 16, 2026
- EPS actual vs est.
- $-0.18 vs —
CNTN news
All CNTN news- Tharimmune, Inc. Reports Third Quarter 2026 Financial and Operational ResultsNasdaq
- Canton Strategic Holdings, Inc. Releases Third Quarter 2026 Financial and Operational ResultsPR Newswire
- Canton Strategic Holdings Issues Statement on MEV and Onchain Transaction Front-RunningPR Newswire
- Tharimmune, Inc. Announces First Trades of Tokenized Common Stock on November 4, 2026Nasdaq
- Tradecraft Becomes First Venue to Support a Tokenized U.S. Stock Transaction Under the SEC Innovation ExemptionPR Newswire
- Tharimmune, Inc. Announces Agreement with TSV LLC to Tokenize Common Stock on the Canton NetworkNasdaq
Canton Strategic peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ORGOOrganogenesis Holdings Inc. Class A | 0.7716 | -2.23% | $100.16M | vs CNTN |
| NERVMinerva Neurosciences Inc | 2.00 | -5.66% | $99.67M | vs CNTN |
| UNCYUnicycive Therapeutics Inc. | 3.35 | -5.10% | $97.77M | vs CNTN |
| FHTXFoghorn Therapeutics Inc. | 1.72 | -3.37% | $103.14M | vs CNTN |
| GNLXGenelux Corporation | 2.17 | -4.82% | $103.36M | vs CNTN |
| NBPNovaBridge Biosciences ADR | 0.83 | -5.66% | $96.28M | vs CNTN |
| PDSBPDS Biotechnology Corporation | 0.7774 | -3.70% | $95.39M | vs CNTN |
| NRXPNRX Pharmaceuticals Inc. | 2.15 | -15.69% | $95.31M | vs CNTN |
Indexes, lists and sector
Canton Strategic stock FAQ
What is Canton Strategic's stock price today?
CNTN last traded at $1.21 as of Nov 20, 4:00 PM EST, down 1.63% on the day. Prices are delayed at least 15 minutes.
Does Canton Strategic pay a dividend?
No. Canton Strategic does not currently pay a regular cash dividend.
What is CNTN's P/E ratio?
CNTN trades at a trailing P/E ratio of 20.17.
Who is Canton Strategic's CEO?
Mr. Mark Wendland is the chief executive officer of Canton Strategic Holdings Inc., which has about 12 employees.
Has CNTN ever split its stock?
Yes. The most recent CNTN stock split was a 1-for-15 split on May 28, 2024, one of 2 splits on record.
What is the CNTN 52-week high?
The 52-week high for CNTN is $5.83 and the 52-week low is $1.19. The stock is currently 79.2% below its high.